95 related articles for article (PubMed ID: 21620501)
21. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control.
Dawson LA; Eccles C; Bissonnette JP; Brock KK
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1247-52. PubMed ID: 15990028
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the planning target volume based on three-dimensional CT and four-dimensional CT images of non-small-cell lung cancer.
Li FX; Li JB; Zhang YJ; Liu TH; Tian SY; Xu M; Shang DP; Ma CS
Radiother Oncol; 2011 May; 99(2):176-80. PubMed ID: 21549440
[TBL] [Abstract][Full Text] [Related]
23. Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer.
Gwynne S; Wills L; Joseph G; John G; Staffurth J; Hurt C; Mukherjee S
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):713-9. PubMed ID: 19733469
[TBL] [Abstract][Full Text] [Related]
24. Effect of a Device-Free Compressed Shell Fixation Method on Hepatic Respiratory Movement: Analysis for Respiratory Amplitude of the Liver and Internal Motions of a Fiducial Marker.
Hashimoto S; Katsurada M; Muramatsu R; Asai K; Tanaka K; Hayashi K; Kibe Y; Nakajima K; Hattori Y; Iwata H; Mizoe JE; Ogino H; Shibamoto Y
Pract Radiat Oncol; 2019 Mar; 9(2):e149-e155. PubMed ID: 30336269
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting target motion in stereotactic body radiotherapy of liver cancer using CyberKnife.
Lo KM; Wu VW; Li Y; Jun Xu H
J Med Imaging Radiat Oncol; 2020 Jun; 64(3):408-413. PubMed ID: 32174026
[TBL] [Abstract][Full Text] [Related]
26. Detection of esophageal fiducial marker displacement during radiation therapy with a 2-dimensional on-board imager: analysis of internal margin for esophageal cancer.
Fukada J; Hanada T; Kawaguchi O; Ohashi T; Takeuchi H; Kitagawa Y; Seki S; Shiraishi Y; Ogata H; Shigematsu N
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):991-8. PubMed ID: 22975614
[TBL] [Abstract][Full Text] [Related]
27. A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size.
Shimizu S; Miyamoto N; Matsuura T; Fujii Y; Umezawa M; Umegaki K; Hiramoto K; Shirato H
PLoS One; 2014; 9(4):e94971. PubMed ID: 24747601
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT.
Gabryś D; Kulik R; Trela K; Ślosarek K
Radiother Oncol; 2011 Sep; 100(3):360-4. PubMed ID: 21974916
[TBL] [Abstract][Full Text] [Related]
29. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters.
Panakis N; McNair HA; Christian JA; Mendes R; Symonds-Tayler JR; Knowles C; Evans PM; Bedford J; Brada M
Radiother Oncol; 2008 Apr; 87(1):65-73. PubMed ID: 18267345
[TBL] [Abstract][Full Text] [Related]
30. Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking.
Zhang J; Wang L; Li X; Huang M; Xu B
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1588-1605. PubMed ID: 33227440
[TBL] [Abstract][Full Text] [Related]
31. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
[TBL] [Abstract][Full Text] [Related]
32. Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer.
Pan X; Zhang X; Li Y; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):601-9. PubMed ID: 19147024
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation between external fiducial positions and internal tumor positions during breath-hold CT.
Hunjan S; Starkschall G; Prado K; Dong L; Balter P
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1586-91. PubMed ID: 20133074
[TBL] [Abstract][Full Text] [Related]
34. Robustness against interfraction prostate movement in scanned ion beam radiation therapy.
Jelen U; Ammazzalorso F; Chanrion MA; Gräf S; Zink K; Engenhart-Cabillic R; Wittig A
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e257-62. PubMed ID: 22677368
[TBL] [Abstract][Full Text] [Related]
35. Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma.
Shin D; Kim TH; Park SY; Kwak J; Moon SH; Yoon M; Lee SB; Park S; Shin KH; Kim DY; Cho KH; Park JW; Kim CM
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):687-94. PubMed ID: 18448269
[TBL] [Abstract][Full Text] [Related]
36. Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer.
Biancia CD; Yorke E; Chui CS; Giraud P; Rosenzweig K; Amols H; Ling C; Mageras GS
Radiother Oncol; 2005 May; 75(2):149-56. PubMed ID: 16086906
[TBL] [Abstract][Full Text] [Related]
37. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
[TBL] [Abstract][Full Text] [Related]
38. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.
Song S; Yenice KM; Kopec M; Liauw SL
Radiother Oncol; 2012 May; 103(2):270-4. PubMed ID: 21890224
[TBL] [Abstract][Full Text] [Related]
39. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
Underberg RW; Lagerwaard FJ; Slotman BJ; Cuijpers JP; Senan S
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):554-60. PubMed ID: 15890600
[TBL] [Abstract][Full Text] [Related]
40. A novel simple approach for incorporation of respiratory motion in stereotactic treatments of lung tumors.
Cuijpers JP; Verbakel WF; Slotman BJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):443-8. PubMed ID: 21047693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
